文献速递类风湿关节炎

手部之外加做前足超声对类风湿关节炎风险患者是否值得:一项纵向队列研究

Ultrasound of the forefeet besides the hands in patients at risk for rheumatoid arthritis: is it worth the effort? A longitudinal cohort study.
PubMed 文献 · Rheumatology (Oxford) · 2025-01-01

在298例临床疑似关节痛患者中,亚临床关节炎症主要见于手部(90-86%),仅10-14%单独见于前足。包含前足与不包含前足的超声方案预测炎症性关节炎发展的风险比相近,曲线下面积在两队列间一致,提示预测类风湿关节炎发展时可省略前足超声。

要点

  • 临床疑似关节痛患者超声阳性时亚临床关节炎症主要位于手部(90-86%),仅10-14%单独位于前足。
  • 全方案、校正后全方案与不含前足方案预测炎症性关节炎的HR在两队列中相近,AUROC一致。
  • 作者结论认为预测类风湿关节炎发展时可省略前足超声。

核心结论

  • 在临床疑似关节痛患者中预测类风湿关节炎发展时,可省略前足超声。
  • 依据是前足亚临床关节炎症不伴手部炎症的情况不常见。

研究设计与样本

  • 两个独立队列的临床疑似关节痛患者接受手部与前足超声检查。
  • 共研究298例临床疑似关节痛患者。
  • 分析类风湿关节炎发展与全超声方案、校正健康人前足灰阶发现的方案及不含前足方案超声阳性之间的关联。

主要发现

  • 超声阳性患者中亚临床关节炎症主要位于手部,占90-86%。
  • 仅10-14%的患者亚临床关节炎症单独位于前足。
  • 全方案超声阳性与炎症性关节炎发展相关,两队列HR分别为2.6(95%CI 0.9-7.5)和3.1(95%CI 1.5-6.4)。
  • 校正后全方案超声阳性与炎症性关节炎发展相关,两队列HR分别为3.1(95%CI 1.3-7.7)和2.7(95%CI 1.3-5.4)。
  • 不含前足方案超声阳性与炎症性关节炎发展相关,两队列HR分别为3.1(95%CI 1.4-6.9)和2.8(95%CI 1.4-5.6)。

关键数值与推荐

  • 全方案超声阳性预测炎症性关节炎发展:队列1 HR 2.6(95%CI 0.9-7.5),队列2 HR 3.1(95%CI 1.5-6.4)。
  • 校正后全方案超声阳性预测炎症性关节炎发展:队列1 HR 3.1(95%CI 1.3-7.7),队列2 HR 2.7(95%CI 1.3-5.4)。
  • 不含前足方案超声阳性预测炎症性关节炎发展:队列1 HR 3.1(95%CI 1.4-6.9),队列2 HR 2.8(95%CI 1.4-5.6)。
  • 两队列AUROC相等。

临床怎么用

  • 原文结论认为预测类风湿关节炎发展时前足超声可省略。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: US can detect subclinical joint-inflammation in patients with clinically suspect arthralgia (CSA), which is valuable as predictor for RA development. In most research protocols both hands and forefeet are scanned, but it is unclear if US of the forefeet has additional value for predicting RA, especially since synovial hypertrophy in MTP-joints of healthy individuals is also common. To explore the possibility to omit scanning of the forefeet we determined if US of the forefeet is of additional predictive value for RA-development in CSA patients. METHODS: CSA patients of two independent cohorts underwent US of the hands and forefeet. We analysed the association between RA-development and US-positivity for the full US-protocol, the full US-protocol with correction for gray scale (GS)-findings in the forefeet of healthy and the protocol without forefeet. RESULTS: In total, 298 CSA patients were studied. In patients with a positive US, subclinical joint-inflammation was mostly present in the hands (90-86%). Only 10-14% of patients had subclinical joint-inflammation solely in the forefeet. US-positivity was associated with inflammatory arthritis development in both cohorts, with HRs 2.6 (95% CI 0.9-7.5) and 3.1 (95% CI 1.5-6.4) for the full protocol, 3.1 (95% CI 1.3-7.7) and 2.7 (95% CI 1.3-5.4) for the full US-protocol with correction, and 3.1 (95% CI 1.4-6.9) and 2.8 (95% CI 1.4-5.6) without the forefeet. AUROCs were equal across both cohorts. CONCLUSION: The forefeet can be omitted when US is used for the prediction of RA-development in CSA patients. This is due to the finding that subclinical joint-inflammation in the forefeet without concomitant inflammation in the hands is infrequent.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Boeren AMP, Oei EHG, Willemze A, et al. Ultrasound of the forefeet besides the hands in patients at risk for rheumatoid arthritis: is it worth the effort? A longitudinal cohort study. Rheumatology (Oxford). 2025. PMID: 38897668. doi:10.1093/rheumatology/keae339

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。